Diagnosis, staging, and workup of gastric cancer

Gastric Cancer: Principles and Practice

Volumn , Issue , 2015, Pages 127-142

  Sabesan, Arvind ^a   Bennett, Joseph J ^a  

^a HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

AJCC 7th edition; Diagnostic laparoscopy; Endoscopic ultrasound; Endoscopy; Gastric cancer; Nomogram

Indexed keywords

EID: 84943599419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-15826-6_8     Document Type: Chapter

References (31)

1. Kamangar F, Dores G, Anderson W. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-50.
2. Roder D. The epidemiology of gastric cancer. Gastric Cancer. 2002;5(1):5-11.
3. Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R, Grothey A, Haller D, Haustermans K, Kerr D, Nordlinger B, Marshall J, Minsky BD, Kang YK, Labianca R, Lordick F, Ohtsu A, Pavlidis N, Roth A, Rougier P, Schmoll HJ, Sobrero A, Taber- nero J, Van de Velde C, Zalcberg J. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22(suppl 5):1-9.
4. Feig B, Ching C. The MD Anderson surgical oncology handbook. Philadelphia: Wolters Kluwer/Lippin- cott Williams & Wilkins; 2012.
5. Chua Y, Cunningham D. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice. Ann Surg Oncol. 2007;14(10):2687-90.
6. Kelsen D. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. J Clin Oncol. 2000;18(suppl 1):32-4.
7. Lee J, Kang W, Lim D, Park J, Park Y, Lim H, Sohn T, Noh J, Bae J, Kim S. Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cis- platin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis. J Clin Oncol. 2009;27(15 S):4537.
8. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077-79.
9. Kwee R, Kwee T. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25(15):2107-16.
10. Layke J, Lopez P. Gastric cancer: diagnosis and treatment options. Am Fam Physician. 2004;69(5): 1133-40.
11. D’Angelica M, Gonen M, Brennan M, Turnbull A, Bains M, Karpeh M. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240(5):808.
12. Longo W, Zucker K, Zdon M, Modlin I. Detection of early gastric cancer in an aggressive endoscopy unit. Am Surg. 1989;55(2):100-4.
13. El Abiad R, Gerke H. Gastric cancer: endoscopic diagnosis and staging. Surg Oncol Clin N Am. 2012;21(1):1-19.
14. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Lara-Santos L, Guilherme M, Moreira-Dias L et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastroin- test Endosc. 2003;57(4):498-504.
15. Mattar R, Andrade C, Difavero G, Gama-Rodrigues J, Laudanna A. Preoperative serum levels of CA 72—4, CEA, CA 19—9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Cl'in. 2002;57(3): 89-92.
16. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M. Prognostic value of preoperative CEA, CA 19—9, CA 72—4, and AFP levels in gastric cancer. Adv Ther. 2008;25(10):1075-84.
17. Graziosi L, Marino E, Cavazzoni E, Donini A. Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer. World J Surg Oncol. 2013;11(1):103.
18. Kattan M, Karpeh M, Mazumdar M, Brennan M. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647-50.
19. Shah M, Khanin R, Tang L, Janjigian Y, Klimstra D, Gerdes H, Kelsen D. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res. 2011;17(9):2693-701.
20. Bang Y, Van Cutsem E, Feyereislova A, Chung H, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase open-label, randomised controlled trial. Lancet. 2010;376(9742):687-97.
21. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. Gastric cancer version 1. 2013.
22. Bhari S, Sup Shim C, Hoon Kim J, Seop Jung I, Young Cho J, et al. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and mul- tiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc. 2004;59(6):619-26.
23. Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73(6):1122-34.
24. Karanicolas P, Elkin E, Jacks L, Atoria C, Strong V, Brennan M, Coit D. Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg. 2011;213(5):644-51.
25. Hopkins S, Yang G. FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol. 2011;2(1):39.
26. Brennan M, Karpeh Jr M. Surgery for gastric cancer: the American view. Semin Oncol. 1996;23(3):352-9.
27. Caletti G, Fusaroli P. The rediscovery of endoscopic ultrasound (EUS) in gastric cancer staging. Endoscopy. 2012;44(06):553-5.
28. Cid’On E, Bustamante R. Gastric cancer: tumor markers as predictive factors for preoperative staging. J Gastrointest Cancer. 2011;42(3):127-30.
29. Crew K, Neugut A, Others. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354.
30. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M. Cancer statistics, 2007. CA: Cancer J Clin. 2007;57(1):43-66.
31. Wanebo H, Kennedy B, Chmiel J, Steele Jr G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American college of surgeons. Ann Surg. 1993;218(5):583.